Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial by Wamil, M, McMurray, JJV, Scott, CAB, Coleman, RL, Sun, Y, Standl, E, Rydén, L, Holman, RR

Corrections needed to 2016 ESC and AHA guidelines on heart failure. by Rydén, L, Van de Werf, F, Armstrong, P, McGuire, D, Standl, E, Peterson, E, Holman, R

Risk factors for fatal and non-fatal cardiovascular events in 9306 subjects in the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial by Mcmurray, J, Laakso, M, Standl, E, Tognoni, G, Holman, R, Giles, T, Martinez, F, Thomas, L, Haffner, S, Califf, R

Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial. by Preiss, D, Giles, T, Thomas, L, Sun, J, Haffner, S, Holman, R, Standl, E, Mazzone, T, Rutten, G, Tognoni, G, Chiang, F, McMurray, J, Califf, R

Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tol... by Preiss, D, Thomas, L, Sun, J, Haffner, S, Holman, R, Standl, E, Leiter, L, Mazzone, T, Rutten, G, Tognoni, G, Martinez, F, Chiang, F, Califf, R, McMurray, J

Assessing the safety of sitagliptin in older participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) by Bethel, M, Engel, S, Green, J, Huang, Z, Josse, R, Kaufman, K, Standl, E, Suryawanshi, S, Van de Werf, F, McGuire, D, Peterson, E, Holman, R, TECOS Study Group

Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglin... by Latini, R, Staszewsky, L, Sun, J, Bethel, M, Disertori, M, Haffner, S, Holman, R, Chang, F, Giles, T, Maggioni, A, Rutten, G, Standl, E, Thomas, L, Tognoni, G, Califf, R, McMurray, J

Association between sitagliptin use and heart failure hospitalization and related outcomes in type 2 diabetes mellitus: secondary analysis of a randomized clinical trial by McGuire, D, Van De Werf, F, Armstrong, P, Standl, E, Koglin, J, Green, J, Bethel, M, Cornel, J, Lopes, R, Halvorsen, S, Ambrosio, G, Buse, J, Josse, R, Lachin, J, Pencina, M, Garg, J, Lokhnygina, Y, Holman, R, Peterson, E